Royalty Pharma plc
SEC CIK 1802768 · RPRX · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bassler Bonnie L | Director | filed 2020 - 2026 |
| Weatherman Elizabeth H | Director | filed 2025 - 2026 |
| Love TED W | Director | filed 2020 - 2026 |
| Hodgson David C | Director | filed 2022 - 2026 |
| Norden Gregory | Director | filed 2020 - 2026 |
| Coric Vlad | Director | filed 2025 - 2026 |
| Ho Carole | Director | filed 2025 - 2026 |
| Engelbert Catherine M. | Director | filed 2020 - 2026 |
| Legorreta Pablo G. | Director · CEO, Chairman of the Board | filed 2020 - 2026 |
| Fernandez Henry A | Director | filed 2020 - 2025 |
| Desouza Errol B | Director | filed 2020 - 2025 |
| Royalty Pharma plc | Director | filed 2025 - 2025 |
| Riggs Rory B | Director | filed 2020 - 2024 |
| Giuliani Mario Germano | Director | filed 2020 - 2024 |
| Avara Management Ltd | Director | filed 2020 - 2024 |
| Ford William E | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hite Christopher | EVP & Vice Chairman | filed 2020 - 2026 |
| Urist Marshall | EVP, Research & Investments | filed 2020 - 2026 |
| Coyne Terrance P. | EVP & CFO | filed 2020 - 2026 |
| Mcgivern Arthur Richard | EVP, Investments & GC | filed 2026 - 2026 |
| Lloyd George W. | EVP, Investments & GC | filed 2020 - 2025 |
| Reddoch James F. | EVP, Research & Investments | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.